[go: up one dir, main page]

FI954991L - Bisyklisiä tetrahydropyrazolopyridiinejä - Google Patents

Bisyklisiä tetrahydropyrazolopyridiinejä Download PDF

Info

Publication number
FI954991L
FI954991L FI954991A FI954991A FI954991L FI 954991 L FI954991 L FI 954991L FI 954991 A FI954991 A FI 954991A FI 954991 A FI954991 A FI 954991A FI 954991 L FI954991 L FI 954991L
Authority
FI
Finland
Prior art keywords
tetrahydropyrazolopyridines
bicyclic
bicyclic tetrahydropyrazolopyridines
Prior art date
Application number
FI954991A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954991A0 (fi
FI954991A7 (fi
Inventor
Allen J Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI954991A0 publication Critical patent/FI954991A0/fi
Publication of FI954991L publication Critical patent/FI954991L/fi
Publication of FI954991A7 publication Critical patent/FI954991A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI954991A 1994-10-20 1995-10-19 Bisyklisiä tetrahydropyrazolopyridiinejä FI954991A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32643494A 1994-10-20 1994-10-20

Publications (3)

Publication Number Publication Date
FI954991A0 FI954991A0 (fi) 1995-10-19
FI954991L true FI954991L (fi) 1996-04-21
FI954991A7 FI954991A7 (fi) 1996-04-21

Family

ID=23272184

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954991A FI954991A7 (fi) 1994-10-20 1995-10-19 Bisyklisiä tetrahydropyrazolopyridiinejä

Country Status (16)

Country Link
EP (1) EP0787132A1 (no)
JP (1) JPH09511758A (no)
KR (1) KR970707124A (no)
CN (1) CN1050129C (no)
AU (1) AU702105B2 (no)
BR (1) BR9504491A (no)
CZ (1) CZ120097A3 (no)
FI (1) FI954991A7 (no)
HU (1) HUT77517A (no)
IL (1) IL115667A0 (no)
MX (1) MX9504422A (no)
NO (1) NO971811L (no)
NZ (1) NZ292991A (no)
PL (1) PL319758A1 (no)
WO (1) WO1996012720A1 (no)
ZA (1) ZA958839B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
CA2258728C (en) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
ES2201299T3 (es) * 1996-06-25 2004-03-16 Pfizer Inc. Derivados sustituidos de indazol y su uso como inhibidores de fosfodiesterasa (pde) de tipo iv y factor de necrosis tumoral (tnf)`.
PT983249E (pt) 1997-05-08 2002-08-30 Pfizer Prod Inc Procesos e intermediarios para a preparacao de derivados de indazole substituidos
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
JP2002533465A (ja) 1998-12-23 2002-10-08 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤としての窒素を含む複素二環類
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
AU777012B2 (en) 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
IL153997A0 (en) * 2000-08-10 2003-07-31 Pharmacia Italia Spa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
US6998408B2 (en) 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
CA2441772A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors
US6750225B2 (en) 2001-04-18 2004-06-15 Bristol-Myers Squibb Pharms Company 1,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitors
JP4196678B2 (ja) * 2001-04-26 2008-12-17 味の素株式会社 複素環化合物
UA78232C2 (uk) 2001-09-21 2007-03-15 Брістол-Майерс Сквібб Компані Лактамвмісні сполуки та їх похідні як інгібітори фактора ха
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
WO2004014374A1 (en) * 2002-07-25 2004-02-19 Pharmacia Italia S.P.A. Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
AR045037A1 (es) 2003-07-10 2005-10-12 Aventis Pharma Sa Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
FR2857363B1 (fr) * 2003-07-10 2007-09-07 Aventis Pharma Sa 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
US7732609B2 (en) * 2005-12-01 2010-06-08 Elan Pharmaceuticals, Inc. 5-(arylsulfonyl)-pyrazolopiperidines
CA2722938A1 (en) * 2008-04-30 2009-11-05 Fredrik Almqvist New peptidomimetic compounds
WO2010088050A2 (en) 2009-01-28 2010-08-05 Cara Therapeutics, Inc. Bicyclic pyrazolo-heterocycles
US7741350B1 (en) 2009-01-28 2010-06-22 Cara Therapeutics, Inc. Bicyclic pyrazolo-heterocycles
EP3152206A1 (en) * 2014-06-06 2017-04-12 Biogen MA Inc. Atx modulating agents
CN115043768A (zh) * 2022-06-20 2022-09-13 新乡市润宇新材料科技有限公司 一种酸促进环丙基开环合成n-芳基吡咯烷-2-酮的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
FR1463883A (fr) * 1964-09-08 1966-07-22 Ciba Geigy Procédé de préparation de triaza-composés bicycliques
BR9406946A (pt) * 1993-07-06 1996-08-06 Pfizer Tetra-hidro-pirazolpiridinas bicíclicas

Also Published As

Publication number Publication date
IL115667A0 (en) 1996-01-19
NO971811L (no) 1997-06-18
JPH09511758A (ja) 1997-11-25
AU702105B2 (en) 1999-02-11
HUT77517A (hu) 1998-05-28
CZ120097A3 (cs) 1998-01-14
AU3531795A (en) 1996-05-15
KR970707124A (ko) 1997-12-01
CN1050129C (zh) 2000-03-08
MX9504422A (es) 1997-04-30
FI954991A0 (fi) 1995-10-19
NZ292991A (en) 1999-02-25
EP0787132A1 (en) 1997-08-06
PL319758A1 (en) 1997-08-18
NO971811D0 (no) 1997-04-18
ZA958839B (en) 1997-04-21
WO1996012720A1 (en) 1996-05-02
CN1161040A (zh) 1997-10-01
FI954991A7 (fi) 1996-04-21
BR9504491A (pt) 1997-05-20

Similar Documents

Publication Publication Date Title
DK0738150T3 (da) Bicykliske fibrinogene antagonister
FI943208A7 (fi) Bisyklisiä tetrahydropyratsolopyridiinejä
FI954991A7 (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
DE59501347D1 (de) Hydroxyphenylharnstoffe
FIU940287U0 (fi) Klaettervaegg
DE59503633D1 (de) Zyklonsichter
BR9506519A (pt) Azatrioxaspiroalquenos
KR950033764U (ko) 관이음쇠
DE59507451D1 (de) Cyanoisoxazole
BR7400683U (pt) Odontoportátil
BR1100457A (pt) Derivados de aroil - piperidina
FI1699U1 (fi) Flerdelad instaellbar profilgestalt
FI1755U1 (fi) Tuggskydd
FI1511U1 (fi) Luftfoerdelningsslang
BR7402342U (pt) Hidro-potenciômetro
BR9401008A (pt) Helistato
BR7401141U (pt) PortA-espoNja
BR7400865U (pt) Multi-arremate
BR9401264A (pt) Prevgás
BR7402083U (pt) Chuveiro-balde
FI943373A0 (fi) Kortsystem
SE9402444D0 (sv) Sågsvärd
KR960007017U (ko) 구이판
BR7400635U (pt) Entopstop
FIU940437U0 (fi) Spegel-strykbraedet-kombination